Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(4):277-283; doi:10.1093/jnci/93.4.277
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jemal, A.
Right arrow Articles by Tarone, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jemal, A.
Right arrow Articles by Tarone, R. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 4, 277-283, February 21, 2001
© 2001 Oxford University Press


CANCER SURVEILLANCE SERIES

Recent Trends in Lung Cancer Mortality in the United States

Ahmedin Jemal, Kenneth C. Chu, Robert E. Tarone

Affiliations of authors: A. Jemal, R. E. Tarone (Division of Cancer Epidemiology and Genetics), K. C. Chu (Office of Special Populations Research), National Cancer Institute, Bethesda, MD.

Correspondence to: Ahmedin Jemal, Ph.D., D.V.M., National Institutes of Health, 6120 Executive Blvd., EPS 8049, Bethesda, MD 20892 (e-mail: Jemala{at}exchange.nih.gov).

Background: Previous age–period–cohort analyses of lung cancer incidence and mortality rates in the United States have demonstrated a decrease in risk by birth cohort through 1950, consistent with declining trends in smoking prevalence. This study was conducted to examine recent lung cancer trends, including trends among the cohorts born after 1950. Methods: Lung cancer mortality rates from 1970 through 1997 for whites aged 24–83 years and for blacks aged 30–83 years were investigated. Using age–period–cohort analyses with 2-year age and 2-year calendar-period intervals, we examined changes in the slope of the trends in birth-cohort and calendar-period effects. All statistical tests are two-sided. Results: There was an unexpected, statistically significant moderation in the rate of decrease of the birth-cohort trend in lung cancer mortality for whites born after 1950, with a corresponding smaller and statistically nonsignificant moderation for blacks. These data are consistent with smoking initiation rates: Rates of both cigarette and marijuana smoking initiation increased for children aged 12–17 years from 1965 through 1977. There was a statistically significant decrease in the slope of the calendar-period trend for lung cancer mortality in 1990 for both whites and blacks that was observed primarily in people 55 years of age and older. Conclusions and Implications: The birth-cohort pattern of lung cancer mortality after 1950 appears to reflect the early impact of teenage cigarette smoking on lung cancer risk in people under the age of 45 years, although a contribution from marijuana smoking cannot be ruled out. This result provides additional support for increasing smoking cessation and prevention programs for teenagers. The calendar-period decrease in lung cancer mortality after 1990 may reflect the long-term benefits of reductions in tobacco carcinogens in cigarettes and increases in smoking cessation beginning around 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
A. K. Adam and A. O. Soubani
Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit
Eur. Respir. J., January 1, 2008; 31(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. G. Shertzer, M. B. Genter, G. Talaska, C. P. Curran, D. W. Nebert, and T. P. Dalton
7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes
Carcinogenesis, June 1, 2007; 28(6): 1371 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Kim, L. You, Z. Xu, K. Kuchenbecker, D. Raz, B. He, and D. Jablons
Wnt inhibitory factor inhibits lung cancer cell growth
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 733 - 737.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. A. Wakelee, E. T. Chang, S. L. Gomez, T. H. Keegan, D. Feskanich, C. A. Clarke, L. Holmberg, L. C. Yong, L. N. Kolonel, M. K. Gould, et al.
Lung Cancer Incidence in Never Smokers
J. Clin. Oncol., February 10, 2007; 25(5): 472 - 478.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L.S. Tai, W. Mak, P. K.M. Ng, D. T.T. Chua, M. Y.M. Ng, L. Fu, K. K.W. Chu, Y. Fang, Y. Qiang Song, M. Chen, et al.
High-throughput Loss-of-Heterozygosity Study of Chromosome 3p in Lung Cancer Using Single-Nucleotide Polymorphism Markers.
Cancer Res., April 15, 2006; 66(8): 4133 - 4138.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. T. Winer-Muram
The solitary pulmonary nodule.
Radiology, April 1, 2006; 239(1): 34 - 49.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. K. Edwards, M. L. Brown, P. A. Wingo, H. L. Howe, E. Ward, L. A. G. Ries, D. Schrag, P. M. Jamison, A. Jemal, X. C. Wu, et al.
Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment
J Natl Cancer Inst, October 5, 2005; 97(19): 1407 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
C. Bosetti, F. Levi, F. Lucchini, E. Negri, and C. L. Vecchia
Lung cancer mortality in European women: recent trends and perspectives
Ann. Onc., October 1, 2005; 16(10): 1597 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Ishibashi, T. Suzuki, S. Suzuki, H. Niikawa, L. Lu, Y. Miki, T. Moriya, S.-i. Hayashi, M. Handa, T. Kondo, et al.
Progesterone Receptor in Non-Small Cell Lung Cancer--A Potent Prognostic Factor and Possible Target for Endocrine Therapy
Cancer Res., July 15, 2005; 65(14): 6450 - 6458.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. E. Tyczynski and H. J. Berkel
Mortality From Lung Cancer and Tobacco Smoking in Ohio (U.S.): Will Increasing Smoking Prevalence Reverse Current Decreases in Mortality?
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1182 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
T. Marugame, I. Yoshimi, K.-i. Kamo, Y. Imamura, S. Kaneko, S. Mizuno, and T. Sobue
Trends in Lung Cancer Mortality Among Young Adults in Japan
Jpn. J. Clin. Oncol., April 1, 2005; 35(4): 177 - 180.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Jemal, E. Ward, and M. J. Thun
Contemporary Lung Cancer Trends among U.S. Women
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 582 - 585.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani
Global Cancer Statistics, 2002
CA Cancer J Clin, March 1, 2005; 55(2): 74 - 108.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
C. Bosetti, M. Malvezzi, L. Chatenoud, E. Negri, F. Levi, and C. La Vecchia
Trends in cancer mortality in the Americas, 1970-2000
Ann. Onc., March 1, 2005; 16(3): 489 - 511.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Buccheri and D. Ferrigno
Lung cancer: clinical presentation and specialist referral time
Eur. Respir. J., December 1, 2004; 24(6): 898 - 904.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
G. King, A. Polednak, R. B. Bendel, M. C. Vilsaint, and S. B. Nahata
Disparities in Smoking Cessation Between African Americans and Whites: 1990-2000
Am J Public Health, November 1, 2004; 94(11): 1965 - 1971.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Ohno, H. Hatabu, D. Takenaka, T. Higashino, H. Watanabe, C. Ohbayashi, M. Yoshimura, M. Satouchi, Y. Nishimura, and K. Sugimura
Metastases in Mediastinal and Hilar Lymph Nodes in Patients with Non-Small Cell Lung Cancer: Quantitative and Qualitative Assessment with STIR Turbo Spin-Echo MR Imaging
Radiology, June 1, 2004; 231(3): 872 - 879.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. M. Libby, J. P. Smith, N. K. Altorki, M. W. Pasmantier, D. Yankelevitz, and C. I. Henschke
Managing the Small Pulmonary Nodule Discovered by CT
Chest, April 1, 2004; 125(4): 1522 - 1529.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
V Esposito, A Baldi, G Tonini, B Vincenzi, M Santini, V Ambrogi, T C Mineo, P Persichetti, G Liuzzi, V Montesarchio, et al.
Analysis of cell cycle regulator proteins in non-small cell lung cancer
J. Clin. Pathol., January 1, 2004; 57(1): 58 - 63.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. Levi, F. Lucchini, E. Negri, and C. La Vecchia
The End of the Tobacco-Related Lung Cancer Epidemic in Europe
J Natl Cancer Inst, April 16, 2003; 95(8): 631 - 632.
[Full Text] [PDF]


Home page
Ann OncolHome page
F. Levi, F. Lucchini, E. Negri, P. Boyle, and C. La Vecchia
Mortality from major cancer sites in the European Union, 1955-1998
Ann. Onc., March 1, 2003; 14(3): 490 - 495.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
I. Yoshimi, A. Ohshima, W. Ajiki, H. Tsukuma, and T. Sobue
A Comparison of Trends in the Incidence Rate of Lung Cancer by Histological Type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA
Jpn. J. Clin. Oncol., February 1, 2003; 33(2): 98 - 104.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
M. J Thun and D. M Burns
Health impact of ""reduced yield"" cigarettes: a critical assessment of the epidemiological evidence
Tob. Control, December 1, 2001; 10(90001): i4 - 11.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.